Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
440.86%
Change (1 year)
Categories
Affimed (AFMD) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $46.53 M
According to Affimed 's latest financial reports the company's total liabilities are $46.53 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Affimed - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $50.97 M | -49.53% |
| 2021-12-31 | $0.10 B | -20.84% |
| 2020-12-31 | $0.12 B | 54.56% |
| 2019-12-31 | $82.55 M | -5.11% |
| 2018-12-31 | $86.99 M | 525.84% |
| 2017-12-31 | $13.9 M | 32.21% |
| 2016-12-31 | $10.51 M | -20.18% |
| 2015-12-31 | $13.17 M | 7.09% |
| 2014-12-31 | $12.3 M | -91.58% |
| 2013-12-31 | $0.14 B | 37.43% |
| 2012-12-31 | $0.10 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $0.85 B | 1,733.53% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.44 M | -99.05% | 🇺🇸 USA |
 Agenus
AGEN | $0.46 B | 893.47% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.30 B | 560.57% | 🇺🇸 USA |